Miguel Barquin
Majadahonda, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 31, 2021
ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma.
Journal: Clinical chemistry and laboratory medicine
Published: October 02, 2020
ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib.
Journal: Translational lung cancer research
Published: July 18, 2020
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Journal: Cancer epidemiology
Published: October 03, 2019
Next-generation sequencing for tumor mutation quantification using liquid biopsies.
Journal: Clinical chemistry and laboratory medicine
Published: July 21, 2019
Peritoneal washing is an adequate source for somatic BRCA1/2 mutation testing in ovarian malignancies.
Journal: Pathology, research and practice
Published: July 18, 2018
Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients.
Journal: Oncotarget
Published: June 15, 2017
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging.
Journal: BMC cancer
Published: August 31, 2016
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency.
Journal: Journal of translational medicine
Published: March 16, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026